Schizophrenia Research
Volume 71, Issue 1 , Pages 167-178 , 1 November 2004

Antisaccade performance is impaired in medically and psychiatrically healthy biological relatives of schizophrenia patients

  • Monica E. Calkins

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1-215-662-7389; fax: +1-215-662-7903.
    • Neuropsychiatry Section, Schizophrenia Research Center, University of Pennsylvania School of Medicine, 10 Gates, 3400 Spruce Street, Philadelphia, PA 19104, USA
    • ,
  • Clayton E. Curtis

      Affiliations

    • Department of Psychology, New York University, USA
    • ,
  • William G. Iacono

      Affiliations

    • Department of Psychology, University of Minnesota, USA
    • ,
  • William M. Grove

      Affiliations

    • Department of Psychology, University of Minnesota, USA

Received 16 July 2003 ,Revised 2 December 2003 ,Accepted 10 December 2003.

References 

  1. Allen J, Lambert A, Johnson F, Schmidt K, Nero K. Antisaccadic eye movements and attentional asymmetry in schizophrenia in three Pacific populations. Acta Psychiatr. Scand. 1996;94:258–265
  2. Bailer U, Leisch F, Meszaros K, Lenzinger E, Willinger U, Strobl R, et al. Genome scan for susceptibility loci for schizophrenia and bipolar disorder. Biol. Psychiatry. 2002;52:40–52
  3. Berrettini WH. Genetics of psychiatric disease. Annu. Rev. Med. 2000;51:465–479
  4. Brenner CA, McDowell JE, Cadenhead KS, Clementz BA. Saccadic inhibition among schizotypal personality disorder subjects. Psychophysiology. 2001;38:399–403
  5. Broerse A, Holthausen EA, van den Bosch RJ, den Boer JA. Does frontal normality exist in schizophrenia? A saccadic eye movement study. Psychiatry Res. 2001;103:167–178
  6. Broerse A, Crawford TJ, den Boer JA. Differential effects of olanzapine and risperidone on cognition in schizophrenia? A saccadic eye movement study. J. Neuropsychiatry Clin. Neurosci. 2002;14:454–460
  7. Brownstein J, Krastoshevsky O, McCollum C, Kundamel S, Matthysse S, Mendell NR, et al. Antisaccade performance is abnormal in schizophrenia patients but not in their biological relatives. Schizophr. Res. 2003;63:13–25
  8. Burke JG, Reveley MA. Improved antisaccade performance with risperidone in schizophrenia. J. Neurol. Neurosurg. Psychiatry. 2002;72:449–454
  9. Butcher J, Williams C. Essentials of MMPI-2 and MMPI-A Interpretation. Minneapolis, MN: University of Minnesota Press; 1992;
  10. Cadenhead KS. Vulnerability markers in the schizophrenia spectrum: implications for phenomenology, genetics, and the identification of the schizophrenia prodrome. Psychiatr. Clin. North Am. 2002;25:837–853
  11. Cadenhead KS, Light GA, Geyer MA, McDowell JE, Braff DL. Neurobiological measures of schizotypal personality disorder: defining an inhibitory endophenotype?. Am. J. Psychiatr. 2002;159:869–871
  12. Calkins ME, Iacono WG. Eye movement dysfunction in schizophrenia: a heritable characteristic for enhancing phenotype definition. Am. J. Med. Genet. 2000;97:72–76
  13. Calkins ME, Katsanis J, Hammer MA, Grove WM, Iacono WG. The misclassification of blinks as saccades: implications for investigations of eye movement dysfunction in schizophrenia. Psychophysiology. 2001;38:761–767
  14. Calkins ME, Curtis CE, Grove WM, Iacono WG. The multiple dimensions of schizotypy in the first-degree biological relatives of schizophrenia patients. Schizophr. Bull. 2003; (In Press)
  15. Calkins ME, Iacono WG, Curtis CE. Smooth pursuit and antisaccade performance evidence trait stability in schizophrenia patients and their relatives. Int. J. Psychophysiol. 2003;49:139–146
  16. Chaudhry IB, Soni SD, Hellewell JS, Deakin JF. Effects of the 5HT antagonist cyproheptadine on neuropsychological function in chronic schizophrenia. Schizophr. Res. 2002;53:17–24
  17. Clementz BA. Psychophysiological measures of (dis)inhibition as liability indicators for schizophrenia. Psychophysiology. 1998;35:648–668
  18. Clementz BA, Grove W, Iacono WG, Sweeney J. Smooth pursuit eye movement dysfunction and liability for schizophrenia: implications for genetic modeling. J. Abnorm. Psychology. 1992;101:117–129
  19. Clementz BA, McDowell JE, Zisook S. Saccadic system functioning among schizophrenia patients and their first-degree biological relatives. J. Abnorm. Psychology. 1994;103:277–286
  20. Cohen J. In: Statistical Power Analysis for the Behavioral Sciences. 2nd ed.. Hillsdale NJ: Lawrence Erlbaum; 1988;
  21. Crawford TJ, Haeger B, Kennard C, Reveley MA, Henderson L. Saccadic abnormalities in psychotic patients: I. Neuroleptic-free psychotic patients. Psychol. Med. 1995;25:461–471
  22. Crawford TJ, Haeger B, Kennard C, Reveley MA, Henderson L. Saccadic abnormalities in psychotic patients: II. The role of neuroleptic treatment. Psychol. Med. 1995;25:473–483
  23. Crawford TJ, Puri B, Nijran KS, Jones B, Kennard C, Lewis SW. Abnormal saccadic distractibility in patients with schizophrenia: a 99mTc-HMPAO SPET study. Psychol. Med. 1996;26:265–277
  24. Crawford TJ, Sharma T, Puri BK, Murray RM, Berridge DM, Lewis SW. Saccadic eye movements in families multiply affected with schizophrenia: the Maudsley family study. Am. J. Psychiatr. 1998;155:1703–1710
  25. Curtis CE, Calkins ME, Grove WM, Feil KJ, Iacono WG. Saccadic disinhibition in acute and remitted schizophrenia patients and their first-degree biological relatives. Am. J. Psychiatr. 2001;158:100–106
  26. Curtis CE, Calkins ME, Iacono WG. Saccadic disinhibition in schizophrenia patients and their first-degree biological relatives: a parametric study of the effects of increasing inhibitory load. Exp. Brain Res. 2001;137:228–236
  27. Depatie L, O'Driscoll GA, Holahan A-LV, Atkinson V, Thavundayil JX, Kin NNY, et al. Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study. Neuropsychopharmacology. 2002;27:1056–1070
  28. Fukushima J, Fukushima K, Chiba T, Tanaka S, Yamashita I, Kato M. Disturbances of voluntary control of saccadic eye movements in schizophrenic patients. Biol. Psychiatry. 1988;23:670–677
  29. Fukushima J, Fukushima K, Morita N, Yamashita I. Further analysis of the control of voluntary saccadic eye movements in schizophrenic patients. Biol. Psychiatry. 1990;28:943–958
  30. Fukushima J, Fukushima K, Morita N, Yamashita I. Disturbances in the control of saccadic eye movement and eye–head coordination in schizophrenics. J. Vestibular Res. Equilib. Orientat. 1991;1:171–180
  31. Fukushima J, Fukushima K, Miyasaka K, Yamashita I. Voluntary control of saccadic eye movement in patients with frontal cortical lesions and Parkinsonian patients in comparison with that in schizophrenics. Biol. Psychiatry. 1994;36:21–30
  32. Gershon ES. Bipolar illness and schizophrenia as oligogenic diseases: implications for the future. Biol. Psychiatry. 2000;47:240–244
  33. Gooding DC. Antisaccade task performance in questionnaire-identified schizotypes. Schizophr. Res. 1999;35
  34. Gooding DC, Tallent KA. The association between antisaccade task and working memory task performance in schizophrenia and bipolar disorder. J. of Nerv. Ment. Dis. 2001;189:8–16
  35. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatr. 2003;160:1–10
  36. Hunter JE, Schmidt FL. Methods of Meta-Analysis: Correcting Error and Bias in Research Findings. Newbury Park, CA: Sage; 1990;
  37. Hutton SB, Crawford TJ, Puri BK, Duncan LJ, Chapman M, Kennard C, et al. Smooth pursuit and saccadic abnormalities in first-episode schizophrenia. Psychol. Med. 1998;28:685–692
  38. Hutton SB, Joyce EM, Barnes TR, Kennard C. Saccadic distractibility in first-episode schizophrenia. Neuropsychologia. 2002;40:1729–1736
  39. Iacono WG. Identifying genetic risk for psychopathology. In:  Routh DK,  DeRubeis RJ editor. The Science of Clinical Psychology: Accomplishments and Future Directions. Washington, DC: American Psychological Association; 1998;p. 3–22
  40. Jackson DN. Jackson Personality Research Form Manual. Port Huron, MI: Research Psychologists Press; 1984;
  41. Karoumi B, Ventre-Dominey J, Vighetto A, Dalery J, d'Amato T. Saccadic eye movements in schizophrenic patients. Psychiatry Res. 1998;77:9–19
  42. Karoumi B, Saoud M, d'Amato T, Rosenfeld F, Denise P, Gutknecht C, et al. Poor performance in smooth pursuit and antisaccadic eye-movement tasks in healthy siblings of patients with schizophrenia. Psychiatry Res. 2001;101:209–219
  43. Katsanis J, Kortenkamp S, Iacono WG, Grove WM. Antisaccade performance in patients with schizophrenia and affective disorder. J. Abnorm. Psychology. 1997;106:468–472
  44. Kendler KS. Diagnostic approaches to schizotypal personality disorder: a historical perspective. Schizophr. Bull. 1985;11:538–553
  45. Kendler KS, McGuire M, Gruenberg AM, O'Hare A, Spellman M, Walsh D. The Roscommon Family Study: III. Schizophrenia-related personality disorders in relatives. Arch. Gen. Psychiatry. 1993;50:781–788
  46. Kendler K, Neale M, Walsh D. Evaluating the spectrum concept of schizophrenia in the Roscommon family study. Am. J. Psychiatr. 1995;152:749–754
  47. Klein C, Heinks T, Andresen B, Berg P, Moritz S. Impaired modulation of the saccadic contingent negative variation preceding antisaccades in schizophrenia. Biol. Psychiatry. 2000;47:978–990
  48. Klein CH, Brugner G, Foerster F, Muller W, Schweickhardt A. The gap effect in pro-saccades and anti-saccades in psychometric schizotypes. Biol. Psychol. 2000;55:25–39
  49. Larrison AL, Ferrante CF, Briand KA, Sereno AB. Schizotypal traits, attention and eye movements. Prog. Neuro-psychopharmacol. Biol. Psychiatry. 2000;24:357–372
  50. Levy DL, Mendell NR, LaVancher CA, Brownstein J, Krastoshevsky O, Teraspulsky L, et al. Disinhibition in antisaccade performance in schizophrenia. In:  Lenzenweger MF,  Dworkin RH editor. Origins and Development of Schizophrenia: Advances in Experimental Psychopathology. 1998;p. 185–210
  51. Malone SM, Iacono WG. Error rate on the antisaccade task: heritability and developmental change in performance among preadolescent and late-adolescent female twin youth. Psychophysiology. 2002;39:664–673
  52. Manoach DS, Lindgren KA, Cherkasova MV, Goff DC, Halpern EF, Intriligator J, et al. Schizophrenic subjects show deficient inhibition but intact task switching on saccadic tasks. Biol. Psychiatry. 2002;51:816–826
  53. Maruff P, Danckert J, Pantelis C, Currie J. Saccadic and attentional abnormalities in patients with schizophrenia. Psychol. Med. 1998;28:1091–1100
  54. Matsue Y, Saito H, Osakabe K, Awata S, Ueno T, Matsuoka H, et al. Smooth pursuit eye movements and voluntary control of saccades in the antisaccade task in schizophrenic patients. Jpn. J. Psychiatry Neurol. 1994;48:13–22
  55. McDowell JE, Clementz BA. The effect of fixation condition manipulations on antisaccade performance in schizophrenia: studies of diagnostic specificity. Exp. Brain Res. 1997;115:333–344
  56. McDowell JE, Myles-Worsley M, Coon H, Byerley W, Clementz BA. Measuring liability for schizophrenia using optimized antisaccade stimulus parameters. Psychophysiology. 1999;36:138–141
  57. McDowell JE, Brown GG, Paulus M, Martinez A, Stewart SE, Dubowitz DJ, et al. Neural correlates of refixation saccades and antisaccades in normal and schizophrenia subjects. Biol. Psychiatry. 2002;51:216–223
  58. Muller N, Riedel M, Eggert T, Straube A. Internally and externally guided voluntary saccades in unmedicated and medicated schizophrenic patients: Part II. Saccadic latency, gain, and fixation suppression errors. Eur. Arch. Psychiatry Clin. Neurosci. 1999;249:7–14
  59. Nieman DH, Bour LJ, Linszen DH, Goede J, Koelman JH, Gersons BP, et al. Neuropsychological and clinical correlates of antisaccade task performance in schizophrenia. Neurology. 2000;54:866–871
  60. Nkam I, Thibaut F, Denise P, Van Der Elst A, Segard L, Brazo P, et al. Saccadic and smooth-pursuit eye movements in deficit and non-deficit schizophrenia. Schizophr. Res. 2001;48:145–153
  61. O'Driscoll GA, Lenzenweger MF, Holzman PS. Antisaccade and smooth pursuit eye tracking and schizotypy. Arch. Gen. Psychiatry. 1998;55:837–843
  62. Radant AD, Claypoole K, Wingerson DK, Cowley DS, Roy-Byrne PP. Relationships between neuropsychological and oculomotor measures in schizophrenia patients and normal controls. Biol. Psychiatry. 1997;42:797–805
  63. Raemaekers M, Jansma JM, Cahn W, Van der Geest JN, van der Linden JA, Kahn RS, et al. Neuronal substrate of the saccadic disinhibition deficit in schizophrenia investigated with 3-dimensional event-related functional magnetic resonance imaging. Arch. Gen. Psychiatry. 2002;59:313–320
  64. Raine A. The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr. Bull. 1991;17:555–564
  65. Ross RG, Harris JG, Olincy A, Radant A, Adler LE, Freedman R. Familial transmission of two independent saccadic abnormalities in schizophrenia. Schizophr. Res. 1998;30:59–70
  66. Rosse RB, Schwartz BL, Kim SY, Deutsch SI. Correlation between antisaccade and Wisconsin card sorting test performance in schizophrenia. Am. J. Psychiatr. 1993;150:333–335
  67. Sereno AB, Holzman PS. Antisaccades and smooth pursuit eye movements in schizophrenia. Biol. Psychiatry. 1995;37:394–401
  68. Sweeney J, Mintun M, Kwee S, Wiseman M, Brown D, Rosenberg D, et al. Positron emission tomography study of voluntary saccadic eye movements and spatial working memory. J. Neurophysiol. 1996;75:454–468
  69. Thaker GK, Kirkpatrick B, Buchanan RW, Ellsberry R, Lahti A, Tamminga C. Oculomotor abnormalities and their clinical correlates in schizophrenia. Psychopharmacol. Bull. 1989;25:491–497
  70. Thaker G, Buchanan R, Kirkpatrick B, Tamminga CA. Oculomotor performance in schizophrenia. In:  Schulz CS,  Tamminga CA editor. Schizophrenia: scientific progress. 1990;p. 115–123
  71. Thaker GK, Cassady S, Adami H, Moran M, Ross D. Eye movements in spectrum personality disorder: comparison of community subjects and relatives of schizophrenic patients. Am. J. Psychiatr. 1996;153:362–368
  72. Thaker GK, Ross DE, Cassady SL, Adami HM, Medoff DR, Sherr J. Saccadic eye movement abnormalities in relatives of patients with schizophrenia. Schizophr. Res. 2000;45:235–244
  73. Webb C, Levinson D. Schizotypal and paranoid personality disorder in the relatives of patients with schizophrenia and affective disorders: a review. Schizophr. Res. 1993;11:81–92

PII: S0920-9964(04)00007-6

doi: 10.1016/j.schres.2003.12.005

Schizophrenia Research
Volume 71, Issue 1 , Pages 167-178 , 1 November 2004

Article Tools